The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of concomitant NSAID and immunotherapy on outcomes in patients with non-small cell lung cancer: Analysis of the National Veterans Health Administration Database.
 
Drew Moghanaki
Honoraria - Varian Medical Systems
Consulting or Advisory Role - AstraZeneca
 
William A. Stokes
No Relationships to Disclose
 
Madhusmita Behera
No Relationships to Disclose
 
Renjian Jiang
No Relationships to Disclose
 
David Gutman
No Relationships to Disclose
 
Felipe Giuste
No Relationships to Disclose
 
Abigail Burns
No Relationships to Disclose
 
Nikhil Sebastian
No Relationships to Disclose
 
Selvi Ramalingam
Consulting or Advisory Role - Amgen (I); AstraZeneca (I); Bristol Myers Squibb (I); Eisai (I); GlaxoSmithKline (I); Lilly (I); Merck (I); Takeda (I)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); Merck (Inst); Takeda (Inst)
 
Vidula Sukhatme
Stock and Other Ownership Interests - Victa (I)
Consulting or Advisory Role - Berg (I); HiFiBiO Therapeutics (I)
Travel, Accommodations, Expenses - HiFiBiO Therapeutics (I)
 
Michael C. Lowe
Research Funding - Bristol-Myers Squibb; Delcath Systems (Inst); Vaccinex (Inst)
 
Suresh S. Ramalingam
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Genentech/Roche; GlaxoSmithKline; Lilly/ImClone; Merck; Mirati Therapeutics; Takeda
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Vikas Sukhatme
Stock and Other Ownership Interests - Victa; Victa
Consulting or Advisory Role - Berg; HiFiBiO Therapeutics
Travel, Accommodations, Expenses - HiFiBiO Therapeutics